The Blitz the Barriers initiative aims to reduce disparities among prostate cancer patients.
Author - David Miller
U.S. joins WHO-led flu vaccine meeting, despite planned...
Two U.S. government agencies that are key players in the World Health Organization-led process to...
Into the Ashtray: FDA’s Previous Proposal to Ban Menthol...
By Sophia R. Gaulkin & Esther Petrikovsky & David B. Clissold — On January 21, 2025, the Trump...
Bio/Pharma Outsourcing Innovation eBook February 2025
Beyond the Data: Making HCP Analytics Actually Work for...
Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to...
Engaging with Launch Partners Early in Development
John Arena, interim president of global pharma services at Cencora, discusses the importance of...
STAT+: Pfizer CEO Albert Bourla inflicts injury on his company...
It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided:...
Popular Flu Vaccine Educational Campaign Ending at CDC
Anonymous reports claim the decision came from new leadership at HHS.
Incyte, Genesis Therapeutics to Use AI Platform to Discover...
The collaboration will utilize Genesis’ proprietary AI platform, initially focusing on targets...
Gilead Treatment for PBC Granted EC Conditional Marketing...
Seladelpar, which is marketed in the US as Livdelzi, was recommended for an orphan drug designation...